商品名通用名申请者批准日期
AMPYRA DALFAMPRIDINE ACORDA THERAPEUTICS INC 1/22/2010
VICTOZA LIRAGLUTIDE NOVO NORDISK INC 1/25/2010
VPRIV VELAGLUCERASE ALFA SHIRE HUMAN IC THERAPIES INC 2/26/2010
CARBAGLU CARGLUMIC ACID ORPHAN EUROPE 3/18/2010
ASCLERA POLIDOCANOL CHEMISCHE FABRIK KREUSSLER AND CO GMBH 3/30/2010
NATAZIA ESTRADIAL VALERATE/DIENOGEST TABS BAYER HEALTHCARE PHARMACEUTICALS INC 5/6/2010
JEVTANA CABAZITAXEL SANOFI AVENTIS US INC 6/17/2010
LASTACAFT VILASTA OPHTHALMIC SOLUTION VISTAKON PHARMACEUTICALS LLC 7/28/2010
ELLA ULIPRISTAL ACETATE LABORATOIRE HRA PHARMA 8/13/2010
Gilenya FINGOLIMOD HCL ORAL CAPSULES NOVARTIS PHARMACEUTICALS CORP 9/21/2010
PRADAXA DABIGATRAN ETEXILATE MESYLATE BOEHRINGER INGELHEIM PHARMACEUTICALS INC 10/19/2010
Latuda LURASIDONE HCL SUNOVION PHARMACEUTICALS INC 10/28/2010
Teflaro CEFTAROLINE FOSAMIL FOR INJECTION CEREXA INC 10/29/2010
Halaven ERIBULIN MESYLATE EISAI INC 11/15/2010
EGRIFTA TESAMORELIN THERATECHNOLOGIES INC 11/10/2010
通用名商品名申请者批准日期
TOCILIZUMAB ACTEMRA GENENTECH, INC. 1/8/2010
CLOSTRIDIAL COLLAGENASE XIAFLEX AUXILIUM PHARMACEUTICALS, INC. 2/2/2010
ALGLUCOSIDASE ALFA2 LUMIZYME GENZYME CORPORATION 5/24/2010
DENOSUMAB TO PROLIA AMGEN, INC. 6/1/2010
INCOBOTULINUMTOXINA XEOMIN MERZ PHARMACEUTICALS GMBH 7/30/2010
PEGLOTICASE KRYSTEXXA SAVIENT PHARMACEUTICALS, INC. 9/14/2010
适应症
INDICATED TO IMPROVE W
2010年FDA批准新药 来自淘豆网m.daumloan.com转载请标明出处.
